Latest Articles
BioNTech’s Promising Phase III Trial for Recurrent Endometrial Cancer - TipRanks
BioNTech’s Promising Phase III Trial for Recurrent Endometrial Cancer TipRanks
Published: July 11, 2025, 4:24 p.m.
Sri Ramakrishna Hospital Celebrates the Science of Hope and Debunks Common IVF Misconceptions to Spread Awareness - The Wire India
Sri Ramakrishna Hospital Celebrates the Science of Hope and Debunks Common IVF Misconceptions to Spread Awareness The Wire India
Published: July 9, 2025, 9:49 a.m.
Gut bacteria and amino acid imbalance linked to higher miscarriage risk in women with PCOS: Study - Medical Dialogues
Gut bacteria and amino acid imbalance linked to higher miscarriage risk in women with PCOS: Study Medical Dialogues
Published: July 8, 2025, 3:30 p.m.
miRNA in Endometriosis-A New Hope or an Illusion?
Background: Endometriosis is a complex, estrogen-dependent condition that can significantly impact women's quality of life and fertility. Current diagnostic strategies remain invasive and often prolonged, demonstrating the need for reliable, …
Published: July 8, 2025, midnight
Teen girl's 'extreme endometriosis pain' dismissed by doctors as 'growing pains' - Daily Record
Teen girl's 'extreme endometriosis pain' dismissed by doctors as 'growing pains' Daily Record
Published: July 6, 2025, 9:01 a.m.
Gut bacteria and amino acid imbalance linked to higher miscarriage risk in women with PCOS - MSN
Gut bacteria and amino acid imbalance linked to higher miscarriage risk in women with PCOS MSN
Published: July 3, 2025, 1:17 p.m.
Organon drops OG-6219 development following trial miss - The Pharma Letter
Organon drops OG-6219 development following trial miss The Pharma Letter
Published: July 3, 2025, 10:55 a.m.
Organon ELENA trial misses primary endpoint, to discontinue OG-6219 program - TipRanks
Organon ELENA trial misses primary endpoint, to discontinue OG-6219 program TipRanks
Published: July 2, 2025, 11:54 a.m.
Organon's Promising Endometriosis Drug OG-6219 Falls Short in Critical Phase 2 Trial, Program Discontinued - Stock Titan
Organon's Promising Endometriosis Drug OG-6219 Falls Short in Critical Phase 2 Trial, Program Discontinued Stock Titan
Published: July 2, 2025, 11:30 a.m.
AstraZeneca Pharma India receives permission to import Durvalumab Solution - Indian Pharma Post
AstraZeneca Pharma India receives permission to import Durvalumab Solution Indian Pharma Post
Published: July 2, 2025, 5:11 a.m.
Link copied to clipboard!